Your Health, We Care
In multiple clinical trials, Ribociclib has shown significant anti-tumor activity and can prolong progression free survival (PFS) in patients.
It can effectively inhibit the proliferation of tumor cells and improve the clinical symptoms of patients, such as tumor size, pain, etc.
